The anti-tumour activity was independent of T regulatory cell (Treg) depletion, as evidenced by similar levels of tumour infiltrating Treg cells in mice treated with the anti-mouse OX40/CD137 mAb2 and isotype control. Here, TNFRSF4 is linked to neoplasm.